Assessment of Synaptic Density in MS

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Steven Cicero) · scicero@bwh.harvard.edu · 617-264-3044
Contact: Principal Investigator (Tarun Singhal, MD)

Study leads

Tarun Singhal, MD
Principal Investigator
Brigham and Women's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

Fibromyalgia · Chronic Fatigue Syndrome · Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis · Primary Progressive Multiple Sclerosis · Secondary Progressive Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

London, United Kingdom

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

St John's, Antigua and Barbuda · Glyfada, Greece

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Bihać, Bosnia and Herzegovina · Sarajevo, Bosnia and Herzegovina